↓ Skip to main content

Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial

Overview of attention for article published in International Archives of Medicine, December 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial
Published in
International Archives of Medicine, December 2013
DOI 10.1186/1755-7682-6-47
Pubmed ID
Authors

Mostafa Amr, Shaheen E Lakhan, Sarila Sanhan, Dahoud Al-Rhaddad, Moussa Hassan, Mohamed Thiabh, Tarek Shams

Abstract

Schizophrenia is a chronic disease of global importance. The second-generation antipsychotic quetiapine has a favorable side-effect profile, however, its clinical effectiveness has been called into question when compared with first-generation antipsychotics such as haloperidol. This study evaluates the efficacy and tolerability of quetiapine versus haloperidol for first-episode schizophrenia in the outpatient setting.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
Uruguay 1 2%
Unknown 42 93%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 18%
Student > Master 6 13%
Researcher 5 11%
Student > Ph. D. Student 5 11%
Student > Doctoral Student 4 9%
Other 7 16%
Unknown 10 22%
Readers by discipline Count As %
Psychology 10 22%
Medicine and Dentistry 8 18%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Neuroscience 3 7%
Agricultural and Biological Sciences 2 4%
Other 4 9%
Unknown 13 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2014.
All research outputs
#22,759,802
of 25,374,917 outputs
Outputs from International Archives of Medicine
#94
of 103 outputs
Outputs of similar age
#282,069
of 320,227 outputs
Outputs of similar age from International Archives of Medicine
#4
of 4 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 103 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,227 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.